• Macrophage EP4 Loss Promotes Atherosclerosis via CD36

  2026-09-24

  Tang and colleagues report that myeloid EP4 deficiency worsens atherosclerotic plaque development in ApoE-deficient mice and is associated with increased macrophage lipid uptake and M1 polarization. Their multi-omics and validation data identify CD36 as a candidate link between EP4 loss and these macrophage phenotypes, while leaving important questions about the pathway’s direct regulation and therapeutic relevance open.

• Br-DAPI for Interpreting Cardiac Lipotoxicity

  2026-09-24

  Br-DAPI is a DAPI fluorescent dye for visualizing cellular DNA, but nuclear signal is not a direct measure of ER stress or apoptosis. This article shows how to use DNA staining as one carefully interpreted layer in diabetic cardiomyopathy experiments, alongside the mechanistic evidence for H₂S deficiency and lipotoxic injury.

• PGE2 Signaling: From Receptor Biology to Translation

  2026-09-23

  Prostaglandin E2 is a powerful but context-dependent signal: its effects depend on receptor subtype, cell state, and experimental design. This article connects EP-receptor biology with emerging arachidonic-acid research and offers a practical framework for translational studies without conflating distinct prostaglandin pathways.

• 2'3'-cGAMP: A Precision STING Assay Workflow

  2026-09-23

  Use 2'3'-cGAMP as a direct STING pathway activator to separate cGAS-dependent DNA sensing from downstream STING regulation. This workflow translates findings from hepatic ischemia–reperfusion research into practical assay designs for inhibitor screening, type I interferon induction, and immunotherapy research.

• Direct Mouse Genotyping Kit Plus for SCA3 Studies

  2026-09-22

  The Direct Mouse Genotyping Kit Plus supports rapid mouse tissue lysis and direct PCR template preparation without DNA purification or precipitation. It combines neutralized lysate workflows with a PCR master mix with dye reagents for mouse genotyping assay development, transgene detection in mice, and colony screening.

• YM 58483 (BTP2): A SOCE Assay Strategy

  2026-09-22

  YM 58483 (BTP2) is a versatile SOCE blocker for separating calcium-entry mechanisms from downstream immune and fibrosis phenotypes. This article translates ORAI2 pathway findings into practical assay design, controls, and interpretation strategies.

• Epinephrine Bitartrate: A Hemodynamic Assay Lens

  2026-09-21

  Epinephrine Bitartrate is a non-selective adrenergic receptor agonist whose effects depend on receptor balance, tissue state, and assay timing. This article presents a state-aware framework for interpreting cardiovascular, airway, and neurobiology experiments without confusing receptor potency with system-level hemodynamics.

• PPARγ, Macrophage Polarization, and DSS-Induced IBD

  2026-09-21

  The reference study identifies a PPARγ–STAT-1/STAT-6 axis that links macrophage polarization with disease severity in a dextran sulfate sodium model of inflammatory bowel disease. Its combined cell and mouse experiments suggest that PPARγ activation suppresses proinflammatory M1 features, promotes M2-associated markers, and improves intestinal barrier injury, while also defining important limits for translation beyond the model.

• Cy3 Goat Anti-Human IgG (H+L) Guide

  2026-09-20

  The Cy3 Goat Anti-Human IgG (H+L) Antibody is a Cy3 conjugated secondary antibody for detecting human immunoglobulins in immunofluorescence, immunohistochemistry, flow cytometry, and ELISA. Its defined fluorescence, affinity purification, and storage formulation support flexible human IgG detection, but the reagent does not establish antiviral neutralization.

• SR-202: PPARγ Antagonism in Translational Research

  2026-09-19

  A mechanism-first analysis of SR-202 as a selective PPARγ antagonist for insulin resistance research, obesity biology, adipocyte differentiation, and immunometabolic pathway validation.

• Carbapenemase Spread in CREC: Guangdong Study

  2026-09-18

  Chen et al. integrate gene localization, antimicrobial susceptibility testing, conjugation, mobile-element analysis, and genotyping to examine carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae across eight teaching hospitals. The findings emphasize the predominance and transferability of plasmid-associated blaNDM-1, while also showing why in vitro transfer results should be interpreted separately from direct hospital transmission.

• Cyclic Pifithrin-α hydrobromide Workflows

  2026-09-18

  Use Cyclic Pifithrin-α hydrobromide to separate p53-dependent stress responses from broader DNA-damage and neuroinflammatory biology. This workflow combines apoptosis, irradiation, and trigeminal pain assays while emphasizing controls that prevent overinterpreting cross-domain results.

• Direct Mouse Genotyping Kit Plus for Macrophage Models

  2026-09-17

  The Direct Mouse Genotyping Kit Plus turns small mouse tissue samples into direct-PCR templates, helping laboratories verify lineage-tracing, reporter, transgenic, and knockout alleles with fewer purification steps. Its dye-containing high-fidelity master mix also simplifies post-PCR gel analysis, while practical controls and troubleshooting guidance help distinguish true genotype calls from lysate or primer artifacts.

• Meropenem Trihydrate: From Mechanism to Translation

  2026-09-17

  A translational framework for using Meropenem trihydrate to connect β-lactam mechanism, resistance phenotyping, metabolomics, and infection-model design without overstating what any single assay can prove.

• 12-O-tetradecanoyl phorbol-13-acetate: PKC/ERK Workflows

  2026-09-16

  TPA provides a rapid, controllable perturbation for dissecting protein kinase C signaling and ERK/MAPK pathway activation in cells, biochemical assays, and approved skin cancer model workflows. This guide emphasizes time-resolved experimental design, practical controls, formulation, and troubleshooting rather than treating TPA as a pathway-specific therapeutic surrogate.

8129 records 1/542 page Next 12345 下5页 Last page